Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| C4 Therapeutics, Inc. | 336,910 | reported | 14 Feb 2026 | tx 9+759,250−8,090 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Feb 2026 | EXERCISE | C4 Therapeutics, Inc. | 7,050 | 0.00 USD | |
| 13 Feb 2026 | GRANT_AWARD | C4 Therapeutics, Inc. | 240,000 | 0.00 USD | |
| 14 Feb 2026 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 2,446 | 1.89 USD | |
| 28 Oct 2025 | EXERCISE | C4 Therapeutics, Inc. | 19,200 | 0.00 USD | |
| 28 Oct 2025 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 5,644 | 2.58 USD | |
| 14 Feb 2025 | GRANT_AWARD | C4 Therapeutics, Inc. | 28,200 | 0.00 USD | |
| 14 Feb 2025 | GRANT_AWARD | C4 Therapeutics, Inc. | 42,400 | 0.00 USD | deriv |
| 28 Oct 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 76,800 | 0.00 USD | |
| 28 Oct 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 345,600 | 0.00 USD | deriv |